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The 1997–2005 tularemia outbreak in Bulgaria affected
285 people. Ten strains were isolated from humans, a tick,
a hare, and water. Amplified fragment length polymorphism
typing of the present isolates and of the strain isolated
in 1962 suggests that a new genetic variant caused the
outbreak. 
T
ularemia is a zoonotic disease caused by the gram-neg-
ative bacterium Francisella tularensis (1). During the
last 10 years, several outbreaks occurred in different coun-
tries, causing tularemia to become a major problem on the
Balkan Peninsula (2–5).
The first Bulgarian F. tularensis strain, isolated in 1962
from a muskrat (Ondatra zibethica) found in the lake of
Srebarna reserve near the Danube River, was designated
Srebarna19 (6). The first 4 tularemia cases in Bulgaria
were reported in 1963 (6,7) after a small epidemic involv-
ing mostly employees in the Srebarna reserve. After 35
years of tularemia surveillance with no cases reported, a
focal epidemic was detected near the end of 1997 (2,8).
New cases appeared, and strains were isolated and charac-
terized. Atotal of 285 cases of tularemia were reported and
registered at the Bulgarian Ministry of Health in the peri-
od 1997–2004 and the first quarter of 2005. The outbreak
areas in 1962 and 1997–2005 in Bulgaria are shown on
Figure 1. The first case of tularemia was reported in
November 1997 in a patient from a small town in the
Slivnitsa region. From 1998 to 2000, 171 cases were
reported (8). The outbreak seemed to abate during 2001
and 2002, when only 16 cases were documented. The inci-
dence increased again in 2003 when 76 new cases were
reported. An area ≈4,000 km2 near the western border with
Serbia and Montenegro was the epidemic focus of the out-
break. 
All the patients exhibited the typical clinical picture of
oropharyngeal, oculoglandular, or ulceroglandular
tularemia. Four (1.4%) of the 285 patients had the oculog-
landular form, 6 (2.1%) had the ulceroglandular form, and
275 (96.5%) had the oropharyngeal form. No deaths, com-
plications, or relapses were observed.
Except for 1 seronegative patient, tularemia cases were
diagnosed according to the confirmed case definition of
the Centers for Disease Control and Prevention (9).
Clinically relevant information was gathered by inter-
views, referral to hospitals, and questionnaires sent to gen-
eral practitioners in the region and submitted to the
reference centers for epidemiologic analysis. Three serum
samples (acute phase, convalescent phrase, and l collected
3 months ± 15 days after the end of therapy) were collect-
ed from all patients (online Appendix; available from
http://www.cdc.gov/ncidod/EID/vol12no04/05-
0709_app.htm). All samples were tested with hemaggluti-
nation and tube-agglutination assays (BulBio-NCIPD,
Sofia, Bulgaria) for anti-Francisella antibodies. 
Fine needle biopsy specimens from enlarged lymph
nodes were processed from 20 patients. Half of the volume
from each specimen was cultured on modified Thayer-
Martin agar (10), and the other half was processed for
polymerase chain reaction (PCR). Water samples, collect-
ed from 41 wells, were also cultured through passage in
guinea pigs (Appendix). Ten strains were isolated, 4 from
patients, 4 from water, 1 from a hare, and 1 from a tick
(Appendix). One of the human isolates (isolate Las) was
from a seronegative patient. Identification of the strains
was performed according to their microbiologic and anti-
genic properties by using standard methods (10). Direct
immunofluorescence assay (IFA) with fluorescein isothio-
cyanate–conjugated anti-Francisella  serum (BulBio-
NCIPD) was used to detect F. tularensis antigens. DNA
from biopsy specimens and strains was subjected to PCR
with tul4 and RD1 primers (11). All investigated biopsy
specimens and strains were PCR and IFA positive. 
16S-PCR restriction fragment length polymorphisms
(RFLP) and amplified fragment length polymorphism
(AFLP) methods were used for molecular typing. For 16S-
PCR RFLP, the genomic DNA was amplified by 16S
rRNA universal primers (12). The 948-bp PCR product
was digested with MboI, RsaI, and HaeIII enzymes. All
strains exhibited a characteristic F. tularensis fingerprint-
ing pattern, and no variations were found. For AFLP, DNA
was digested with HindIII and MboI enzymes, adaptors
were ligated, and selective PCR was carried out with
Hind+0 and Mbo+C primers. Pearson correlation and
unweighted pair group method with arithmetic averages
(UPGMA) algorithms were applied for generating dendro-
gram (Figure 2). Three of the water isolates showed 100%
similarity, and only 1 (Aqua D) was included in the den-
drogram (Figure 2). A set of DNA samples from 27
F. tularensis strains originating from Asia, Europe,
America, and Bulgaria were also typed. The AFLP method
clearly discriminated the representatives of different
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patterns show little variability (<25%, Figure 2), distinc-
tive clusters are seen. All of the subspecies holarctica clus-
ter away from the subspecies tularensis. The fingerprinting
pattern of a strain Srebarna19, isolated in 1962 during an
outbreak near the Lake of Srebarna, shows high similarity
with fingerprints of strains isolated in Europe (e.g., the
335–64, Italy 1964, Figure 2). The dendrogram clearly
shows divergence between the 1962 Srebarna19 strain and
the organisms associated with the current outbreak. The
human, water, and animal isolates from the current out-
break have ≈95% similarity. The human isolates are close-
ly related to isolates recovered from well water but are
more distantly related to isolates from the hare and tick.
The AFLP data of isolates from the current outbreak sup-
port the hypothesis of a new genotype emerging in
Bulgaria. AFLP also shows the emerging isolates to be
genetically distinct from the European, Asian, and
American isolates evaluated in this study.
Several publications describe outbreaks in the Balkan
Peninsula with healthcare importance (3–5). Ten F.
tularensis strains were isolated in Turkey (3). However,
they were not genetically characterized. No isolation was
attempted during the Kosovo outbreak in 1999 (5). 
The origin of the 10 strains from the current outbreak
is controversial, but they are clearly distinct from the
other worldwide isolates included in our study. The new
outbreak may be a result of the agricultural reorganiza-
tions in Bulgaria in 1990s. These changes affected the
way in which the arable soil was ploughed, leaving rodent
holes intact. As a result, the populations of rodents, con-
sidered the main reservoir of the infection, increased sub-
stantially (13). 
Francisella  organisms can survive in water for pro-
longed periods, probably by interaction with protozoa
(14). The isolation of bacteria from 4 private wells in the
affected area points to ingestion of contaminated food or
drinking water as the probable route of infection. This
finding is further supported by the observation that most of
the cases represent the oropharyngeal form. Rodents (or
their excrement) could be the source for water contamina-
tion, but this hypothesis is not confirmable because of the
lack of later rodent isolates for comparison. 
The organism might have been introduced by means of
rodents and hares through the border with Serbia and
Montenegro. Agricultural practices are alike in the neigh-
boring countries, and a similar boom in the rodent popula-
tion might also have occurred there. Such a migration is
bidirectional, but a future collaborative study with col-
leagues from Serbia and Macedonia, where tularemia is
also problematic, is necessary to answer this question.
Typing isolates originating from different Balkan countries
will show the genetic relatedness and biodiversity among
resident F. tularensis populations. 
The cases reported in 2004 and 2005 suggest that the
outbreak is still in progress. These are the first data for
genetic identification and typing of isolates from the
Balkan region, and they show a new genotype of F.
tularensis emerging as a cause of human disease in
Bulgaria.
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Figure 1. The outbreak areas, Bulgaria, 1962 and 1997–2005.
Figure 2. Amplified fragment length polymorphism dendrogram.Dr Kantardjiev is professor of medicine, microbiology, and
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